204 related articles for article (PubMed ID: 34887387)
21. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.
Steger DJ; Lefterova MI; Ying L; Stonestrom AJ; Schupp M; Zhuo D; Vakoc AL; Kim JE; Chen J; Lazar MA; Blobel GA; Vakoc CR
Mol Cell Biol; 2008 Apr; 28(8):2825-39. PubMed ID: 18285465
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation.
Kim W; Kim R; Park G; Park JW; Kim JE
J Biol Chem; 2012 Feb; 287(8):5588-99. PubMed ID: 22190683
[TBL] [Abstract][Full Text] [Related]
23. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
[TBL] [Abstract][Full Text] [Related]
24. Histone monoubiquitylation position determines specificity and direction of enzymatic cross-talk with histone methyltransferases Dot1L and PRC2.
Whitcomb SJ; Fierz B; McGinty RK; Holt M; Ito T; Muir TW; Allis CD
J Biol Chem; 2012 Jul; 287(28):23718-25. PubMed ID: 22619169
[TBL] [Abstract][Full Text] [Related]
25. DOT1L bridges transcription and heterochromatin formation at mammalian pericentromeres.
Malla AB; Yu H; Farris D; Kadimi S; Lam TT; Cox AL; Smith ZD; Lesch BJ
EMBO Rep; 2023 Aug; 24(8):e56492. PubMed ID: 37317657
[TBL] [Abstract][Full Text] [Related]
26. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
27. DOT1L and H3K79 Methylation in Transcription and Genomic Stability.
Wood K; Tellier M; Murphy S
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29495487
[TBL] [Abstract][Full Text] [Related]
28. A novel role of DOT1L in kidney diseases.
Wei W; Zhao Y; Chai Y; Shou S; Jin H
Mol Biol Rep; 2023 Jun; 50(6):5415-5423. PubMed ID: 37085741
[TBL] [Abstract][Full Text] [Related]
29. Histone methyltransferase Dot1L plays a role in postembryonic development in Xenopus tropicalis.
Wen L; Fu L; Guo X; Chen Y; Shi YB
FASEB J; 2015 Feb; 29(2):385-93. PubMed ID: 25366346
[TBL] [Abstract][Full Text] [Related]
30. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.
Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855
[TBL] [Abstract][Full Text] [Related]
31. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation.
Aslam MA; Alemdehy MF; Kwesi-Maliepaard EM; Muhaimin FI; Caganova M; Pardieck IN; van den Brand T; van Welsem T; de Rink I; Song JY; de Wit E; Arens R; Jacobs H; van Leeuwen F
EMBO Rep; 2021 Feb; 22(2):e51184. PubMed ID: 33410591
[TBL] [Abstract][Full Text] [Related]
32. The upstreams and downstreams of H3K79 methylation by DOT1L.
Vlaming H; van Leeuwen F
Chromosoma; 2016 Sep; 125(4):593-605. PubMed ID: 26728620
[TBL] [Abstract][Full Text] [Related]
33. DOT1L promotes spermatid differentiation by regulating expression of genes required for histone-to-protamine replacement.
Malla AB; Rainsford SR; Smith ZD; Lesch BJ
Development; 2023 May; 150(9):. PubMed ID: 37082969
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity analysis of semisynthetic nucleosomes: mechanistic insights into the stimulation of Dot1L by ubiquitylated histone H2B.
McGinty RK; Köhn M; Chatterjee C; Chiang KP; Pratt MR; Muir TW
ACS Chem Biol; 2009 Nov; 4(11):958-68. PubMed ID: 19799466
[TBL] [Abstract][Full Text] [Related]
35. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R
Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias.
Banday S; Farooq Z; Ganai SA; Altaf M
Clin Epigenetics; 2020 May; 12(1):73. PubMed ID: 32450905
[TBL] [Abstract][Full Text] [Related]
37. Maternal DOT1L is dispensable for mouse development.
Liao J; Szabó PE
Sci Rep; 2020 Nov; 10(1):20636. PubMed ID: 33244015
[TBL] [Abstract][Full Text] [Related]
38. Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
Chen J; Park HJ
ACS Chem Biol; 2019 May; 14(5):873-881. PubMed ID: 30951287
[TBL] [Abstract][Full Text] [Related]
39. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
40. Histone methyltransferase Dot1L inhibits pancreatic cancer cell apoptosis by promoting NUPR1 expression.
Shan L; Hao C; Jun Z; Qinghe C
J Int Med Res; 2022 Mar; 50(3):3000605221088431. PubMed ID: 35350907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
